226 related articles for article (PubMed ID: 6177973)
1. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass.
Sade RM; Crawford FA; Dearing JP; Stroud M
J Thorac Cardiovasc Surg; 1982 Jul; 84(1):35-8. PubMed ID: 6177973
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
[TBL] [Abstract][Full Text] [Related]
4. The effect of Trendelenburg position, lactated Ringer's solution and 6% hydroxyethyl starch solution on cardiac output after spinal anesthesia.
Zorko N; Kamenik M; Starc V
Anesth Analg; 2009 Feb; 108(2):655-9. PubMed ID: 19151304
[TBL] [Abstract][Full Text] [Related]
5. Cold-induced fluid extravasation during cardiopulmonary bypass in piglets can be counteracted by use of iso-oncotic prime.
Farstad M; Kvalheim VL; Husby P
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):287-94. PubMed ID: 16077389
[TBL] [Abstract][Full Text] [Related]
6. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
Ooi JS; Ramzisham AR; Zamrin MD
Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
[TBL] [Abstract][Full Text] [Related]
7. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
Choi YS; Shim JK; Hong SW; Kim JC; Kwak YL
Minerva Anestesiol; 2010 Aug; 76(8):584-91. PubMed ID: 20661198
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials.
Navickis RJ; Haynes GR; Wilkes MM
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):223-30. PubMed ID: 22578894
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary study of colloid osmotic pressure for cardiopulmonary bypass].
Wang D; Xiang L; Luo J
Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):751-3. PubMed ID: 9590779
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hydroxyethyl starch and ringer lactate as a prime solution regarding S-100beta protein levels and informative cognitive tests in cerebral injury.
Iriz E; Kolbakir F; Akar H; Adam B; Keceligil HT
Ann Thorac Surg; 2005 Feb; 79(2):666-71. PubMed ID: 15680855
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass.
Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W
Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028
[TBL] [Abstract][Full Text] [Related]
13. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
14. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
15. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial.
Svendsen ØS; Farstad M; Mongstad A; Haaverstad R; Husby P; Kvalheim VL
Perfusion; 2018 Sep; 33(6):483-489. PubMed ID: 29199540
[TBL] [Abstract][Full Text] [Related]
16. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
17. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
[TBL] [Abstract][Full Text] [Related]
18. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery.
Miao N; Yang J; Du Z; Liu W; Ni H; Xing J; Yang X; Xu B; Hou X
Perfusion; 2014 Sep; 29(5):462-8. PubMed ID: 24658707
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients.
Tigchelaar I; Gallandat Huet RC; Boonstra PW; van Oeveren W
Perfusion; 1998 Sep; 13(5):297-303. PubMed ID: 9778712
[TBL] [Abstract][Full Text] [Related]
20. The influence of priming solutions used in cardiopulmonary bypass on blood viscosity in hypothermic conditions.
Manduz S; Sapmaz I; Sanri US; Karahan O; Bascil H; Dogan K
ASAIO J; 2008; 54(3):275-7. PubMed ID: 18496277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
